U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2009
359
Substance Class Protein
Created
by admin
on Fri Dec 15 16:41:40 GMT 2023
Edited
by admin
on Fri Dec 15 16:41:40 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
FU77B4U5Z0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
USTEKINUMAB
DASH   EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
CNTO-1275
Code English
USTEKINUMAB [JAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 12 P40 SUBUNIT) (HUMAN MONOCLONAL CNTO 1275 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CNTO 1275 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 12 P40 SUBUNIT) (HUMAN MONOCLONAL CNTO 1275 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL CNTO 1275 .KAPPA.-CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-12 SUBUNIT BETA (IL-12B, CLMF P40, NKSF2)) (HUMAN MONOCLONAL CNTO 1275 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL CNTO 1275 .KAPPA.-CHAIN, DIMER
Common Name English
ustekinumab [INN]
Common Name English
USTEKINUMAB [MI]
Common Name English
USTEKINUMAB [USAN]
Common Name English
USTEKINUMAB [PURPLE BOOK CDER]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-12 SUBUNIT BETA (IL-12B, CLMF P40, NKSF2)) (HUMAN MONOCLONAL CNTO 1275 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CNTO 1275 .KAPPA.-CHAIN, DIMER
Common Name English
TT-20
Code English
USTEKINUMAB [EMA EPAR]
Common Name English
STELARA
Brand Name English
CNTO 1275
Code English
USTEKINUMAB [VANDF]
Common Name English
USTEKINUMAB [MART.]
Common Name English
Ustekinumab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 537516
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
EMA ASSESSMENT REPORTS STELARA (AUTHORIZED: ARTHRITIS, PSORIATIC)
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
FDA ORPHAN DRUG 520916
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
FDA ORPHAN DRUG 314510
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
NDF-RT N0000192797
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
NDF-RT N0000192799
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
WHO-ATC L04AC05
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
FDA ORPHAN DRUG 343811
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
NCI_THESAURUS C20401
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
FDA ORPHAN DRUG 586217
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
LIVERTOX NBK548014
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
WHO-VATC QL04AC05
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
FDA ORPHAN DRUG 358111
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL1201835
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
IUPHAR
6885
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
DRUG BANK
DB05679
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
WIKIPEDIA
USTEKINUMAB
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
DAILYMED
FU77B4U5Z0
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
FDA UNII
FU77B4U5Z0
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
EVMPD
SUB27761
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
SMS_ID
100000091702
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
DRUG CENTRAL
4966
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
CAS
815610-63-0
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
USAN
TT-20
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
MESH
C504320
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
NCI_THESAURUS
C84237
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
INN
8954
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
RXCUI
847083
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY RxNorm
MERCK INDEX
m11349
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY Merck Index
LACTMED
Ustekinumab
Created by admin on Fri Dec 15 16:41:40 GMT 2023 , Edited by admin on Fri Dec 15 16:41:40 GMT 2023
PRIMARY
From To
1_22 1_96
1_146 1_202
1_222 3_214
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
2_22 2_96
2_146 2_202
2_222 4_214
2_263 2_323
2_369 2_427
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Related Record Type Details
INTERLEUKIN-23 SUBUNIT ALPHA
TARGET -> INHIBITOR
INTERLEUKIN-12 HUMAN
TARGET -> INHIBITOR
Related Record Type Details
USTEKINUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:SEQUENCE CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966